Cargando…

Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke

BACKGROUND: Thrombolysis and endovascular thrombectomy are the primary treatment for ischemic stroke. However, due to the limited time window and the occurrence of adverse effects, only a small number of patients can genuinely benefit from recanalization. Intraarterial injection of rtPA (recombinant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yuyou, Gu, Shanshan, Han, Ziping, Yang, Zhenghong, Zhong, Liyuan, Li, Lingzi, Wang, Rongliang, Yan, Feng, Luo, Yumin, Borlongan, Cesario, Lu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547350/ https://www.ncbi.nlm.nih.gov/pubmed/37655472 http://dx.doi.org/10.1161/JAHA.123.029817

Ejemplares similares

Neutrophilic noncoding RNAs predict outcomes of acute ischemic stroke patients treated with recombinant tissue plasminogen activator
por: Han, Ziping, et al.
Publicado: (2022)

Elevated plasma syndecan-1 as glycocalyx injury marker predicts unfavorable outcomes after rt-PA intravenous thrombolysis in acute ischemic stroke
por: Zhao, Fangfang, et al.
Publicado: (2022)

Circulating Inflammatory Biomarkers Level before Thrombolysis for Acute Ischemic Stroke Predicts Symptomatic Intracerebral Hemorrhage
por: Li, Lingzhi, et al.
Publicado: (2023)

Crosstalk between Inflammation and the BBB in Stroke
por: Huang, Yuyou, et al.
Publicado: (2020)

Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis
por: Yang, Hung-Wei, et al.
Publicado: (2012)

Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis in a Patient with Acute Ischemic Stroke Secondary to Aortic Dissection
por: Hong, Keun-Sik, et al.
Publicado: (2009)

Hyperacute thrombolysis with recombinant tissue plasminogen activator of acute ischemic stroke: Feasibility and effectivity from an Indian perspective
por: Sharma, S. R., et al.
Publicado: (2008)

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients over 80 Years Old: The Fukuoka Stroke Registry
por: Matsuo, Ryu, et al.
Publicado: (2014)

Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis
por: HIRANO, Teruyuki
Publicado: (2015)

Thrombolysis with Systemic Recombinant Tissue Plasminogen Activator in Children: A Multicenter Retrospective Study
por: Zengin, Emine, et al.
Publicado: (2021)

Left ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic stroke
por: Doepp, Florian, et al.
Publicado: (2005)

Outcome after systemic thrombolysis is predicted by age and stroke severity: an open label experience with recombinant tissue plasminogen activator and tirofiban
por: Seitz, Rüdiger J., et al.
Publicado: (2012)

A Retrospective Study of thrombolysis with 0.6 mg/kg Recombinant Tissue Plasminogen Activator (rt-PA) in Mild Stroke
por: Yang, Jie, et al.
Publicado: (2016)

Relationship between homocysteine level and prognosis of elderly patients with acute ischemic stroke treated by thrombolysis with recombinant tissue plasminogen activator
por: Li, Juan, et al.
Publicado: (2019)

Dysregulation of Principal Circulating miRNAs in Non-human Primates Following Ischemic Stroke
por: Chen, Jian, et al.
Publicado: (2021)

Oxytocin modulates GABA(A)R subunits to confer neuroprotection in stroke in vitro
por: Kaneko, Yuji, et al.
Publicado: (2016)

Strategies for Study of Neuroprotection from Cold-preconditioning
por: Mitchell, Heidi M., et al.
Publicado: (2010)

Association of admission neutrophil serine proteinases levels with the outcomes of acute ischemic stroke: a prospective cohort study
por: Li, Lingzhi, et al.
Publicado: (2023)

Impact of SMTP Targeting Plasminogen and Soluble Epoxide Hydrolase on Thrombolysis, Inflammation, and Ischemic Stroke
por: Hasumi, Keiji, et al.
Publicado: (2021)

Systemic thrombolysis with recombinant tissue plasminogen activator for acute life-threatening Blalock-Taussig shunt obstruction
por: Diaz, Franco, et al.
Publicado: (2016)

Successful thrombolysis with recombinant tissue plasminogen activator after antagonizing dabigatran by idarucizumab: a case report
por: Gawehn, Annemarie, et al.
Publicado: (2016)

3rd International Conference on Cold Fusion : Frontiers of Cold Fusion
por: Ikegami, H
Publicado: (1992)

Effect of glycated hemoglobin index and mean arterial pressure on acute ischemic stroke prognosis after intravenous thrombolysis with recombinant tissue plasminogen activator
por: Liu, Shi-Ying, et al.
Publicado: (2018)

Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society
por: TOYODA, Kazunori, et al.
Publicado: (2019)

Prognostic significance of plasma IL-2 and sIL-2Rα in patients with first-ever ischaemic stroke
por: Zhao, Haiping, et al.
Publicado: (2020)

sLOX-1: A Molecule for Evaluating the Prognosis of Recurrent Ischemic Stroke
por: Zheng, Yangmin, et al.
Publicado: (2021)

The Incremental Prognostic Value of Hepatocyte Growth Factor in First-Ever Acute Ischemic Stroke: An Early Link Between Growth Factor and Interleukins
por: Li, Fangfang, et al.
Publicado: (2021)

Melatonin-Based Therapeutics for Neuroprotection in Stroke
por: Shinozuka, Kazutaka, et al.
Publicado: (2013)

Neuroprotective Effects of Liraglutide for Stroke Model of Rats
por: Sato, Kenichiro, et al.
Publicado: (2013)

Negative Fluid-Attenuated Inversion Recovery-Based Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator in Acute Stroke Patients with Unknown Onset Time
por: Aoki, Junya, et al.
Publicado: (2013)

Effect of glycated hemoglobin index and mean arterial pressure on acute ischemic stroke prognosis after intravenous thrombolysis with recombinant tissue plasminogen activator: Erratum
Publicado: (2019)

Concise Review: Stem Cell Therapy for Stroke Patients: Are We There Yet?
por: Borlongan, Cesario V.
Publicado: (2019)

T-Regulatory Cells Confer Increased Myelination and Stem Cell Activity after Stroke-Induced White Matter Injury
por: Zarriello, Sydney, et al.
Publicado: (2019)

Conference on Cold Gas at High Redshift
por: Collective
Publicado: (1995)

Angioedema after thrombolysis with tissue plasminogen activator: an airway emergency
por: Rathbun, Kimberly M
Publicado: (2019)

Targeted thrombolysis strategies for neuroprotective effect
por: Zhang, Junping, et al.
Publicado: (2014)

Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator
por: Knecht, Talia, et al.
Publicado: (2018)

Effects of erythropoietin combined with tissue plasminogen activator on the rats following cerebral ischemia and reperfusion
por: Wang, Rongliang, et al.
Publicado: (2016)

MiR-29a Knockout Aggravates Neurological Damage by Pre-polarizing M1 Microglia in Experimental Rat Models of Acute Stroke
por: Zhao, Fangfang, et al.
Publicado: (2021)

Stem Cell Transplantation for Neuroprotection in Stroke
por: Shinozuka, Kazutaka, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r54mrcvpgjnv98o0n34fa1pgsr